Total Funding
42
11
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
678961
Synthelis is a biotech company specialized in production, purification, and characterization of membrane proteins.
- Paul Bonnabel: General Manager
- Sandra Cortes: Scientific Director
About the Company
Synthelis is a French biotech company specialized in production, purification, and characterization of membrane proteins and other difficult-to-express proteins such as ion channels, membrane transporters, GPCRs, membrane enzymes, and antigens.
Based on patented cell-free technology, it provides products and services to deliver functional proteins
as proteoliposomes or in a soluble detergent format. As a result it supports pharmaceutical companies, biotech companies, and academic teams in applications such as vaccine development, screening and display technologies, protein delivery, in vitro diagnostics, and structural biology.
Synthelis was founded on 2011 and is based in La Tronche, France.
